MedTech Dive May 9, 2023
By Elise Reuter

Dive Brief:

  • Samsung has received clearance from the U.S. Food and Drug Administration for an irregular heart rhythm notification feature for its Galaxy Watch devices to passively monitor wearers for signs of atrial fibrillation (Afib).
  • The feature uses a sensor built into the Galaxy Watch, and an electrocardiogram function that Samsung added to its Health Monitor app, which already allowed people to take an ECG reading and flagged potential cases of Afib.
  • With the ability to monitor for arrhythmias, Samsung is now able to compete with Apple and Fitbit, which have similar features in their smartwatches.

Dive Insight:

AFib, one of the most common heart arrhythmias, can lead to stroke and heart failure. Recently, companies have been...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, FDA, Govt Agencies, Technology, Wearables
Related Articles:
Oura Ring Is ‘Like An Apple Product’ And Could Take Key Health Metric Mainstream
Wearable ultrasound sensor revolutionizes continuous blood pressure monitoring
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review

Share This Article